New year, new trials: Analysis reveals clinical trial activity trends in 2023
A new report by GlobalData previews the upcoming initiations and completions of clinical trials in the new year....
06 January, 2023
Clinical Trials
Two first-in-kind clinical trials explore psilocybin for substance misuse
Professor Paul Hutson and collaborators in the Transdisciplinary Center for Research in Psychoactive Substances study psilocybin for opioid and methamphetamine use disorders....
06 January, 2023
Lab-grown retinal eye cells make successful connections, open door for clinical trials to treat blindness
Retinal cells grown from stem cells can reach out and connect with neighbors, according to a new study, completing a “handshake” that may show the cells are ready for clinical trials....
04 January, 2023
Enhancing diversity in clinical trial populations: An agency-industry perspective
Achieving clinical trial diversity will require a multi-stakeholder approach across the healthcare ecosystem, including efforts by government agencies, health systems, and industry....
31 December, 2022
A new HIV treatment shot is given only twice a year. It could be a ‘game changer’
The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens....
30 December, 2022
Two straightforward ways to improve DE&I in clinical trials
While the use of digital health technologies has increased in clinical trials, securing patients' trust continues to be a significant challenge. These technologies may help build trust by helping to increase representation in clinical trials....
27 December, 2022
Technology advances how we design clinical trials: Wearables, devices, and data
Clinical researchers and study teams around the globe have widely adopted technology solutions that will forever change how clinical trials are designed and conducted moving forward....
22 December, 2022
Does patient telehealth use affect breast cancer trial enrollment?
A study presented at the San Antonio Breast Cancer Symposium aimed to identify factors associated with patient preference for an initial consult via telemedicine and whether there was a correlation with clinical trial enrollment....
22 December, 2022
Development velocity: Longstanding challenges in drug development
Throughout 2022, clinical research leaders have expressed concerns about the economic and public health challenges that result from slow drug development. After fast-tracked COVID-19 therapies proved development can be accelerated, the status quo is being challenged....
20 December, 2022
Innovate to increase diversity in cancer clinical trials
The global life sciences industry has much to learn to bridge the diversity divide in cancer clinical trial participation. The good news is advanced technology can help—it’s time to leverage such modern innovations as artificial intelligence (AI), digital tools, and analytics software to move the...
20 December, 2022